Real-time PCR demonstrated that LYC blocked bleomycin-induced expression of type I collagen, Acta2, and Fn, and reduced α-SMA and FN levels, improving bleomycin-induced pulmonary fibrosis. The gene discussed is FN1; the disease is pulmonary fibrosis.